Ramaswamy Sundararajan

7PUBLICATIONS
15CO-AUTHORS
Disease surveillanceImmunogenetics (incl. genetic immunology)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 23, 2026
Respiratory syncytial virus incidence and clinical outcomes in patients with inflammatory bowel disease: a National Veterans Affairs cohort study.

|Oct 16, 2025
Comparative Risk of Serious Infections Associated With Treatment of Inflammatory Bowel Disease.

Nabeel Khan, Ramaswamy Sundararajan, Dhruvan Patel

|Jul 18, 2025
Long-Term Effectiveness and Safety of Tofacitinib in a Nationwide Veterans Affairs Cohort of Ulcerative Colitis Patients.

Nabeel Khan, Ramaswamy Sundararajan, Nadim Mahmud

|Oct 22, 2024
Incidence of Thiopurine-Induced Severe Myelosuppression in a Nationwide Cohort of Patients With Inflammatory Bowel Disease.

Nabeel Khan, Dhruvan Patel, Ramaswamy Sundararajan

|Aug 27, 2024
Clinical Course of Bio Naive Ulcerative Colitis Patients Five Years After Initiation of Adalimumab in a Nationwide Cohort.

Ramaswamy Sundararajan, Manthankumar Patel, Janak Bahirwani

|Mar 14, 2024
Effectiveness of Tofacitinib in Patients With Ulcerative Colitis: A Nationwide Veterans Administration Cohort Study.

Nabeel Khan, Ramaswamy Sundararajan, Manthankumar Patel

Pageof 2

Frequent Collaborators

6 joint publications

Nabeel Khan

3 joint publications

Nadim Mahmud

3 joint publications

Manthankumar Patel

2 joint publications

Janak Bahirwani